Intrinsic Value

BioCryst Pharmaceuticals, Inc. (BCRX)


-0.25 (-2.02%)
Enterprise Value -
Net Debt 88.85
Equity Value -
Shares Outstanding 179.12
Equity Value Per Share -

Because investors are more interested in the value of the company’s shares alone, we’ll deduct net debt from this value to arrive at a fair value of the company’s equity. Fair Value = Enterprise Value – Debt